Evidence suggests that the justification for a 25 percent import tariff on Canadian goods and services does not hold up to ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Sen. Elizabeth Warren grilled Robert F. Kennedy Jr. over his plans to profit off of drug companies or lawsuits after being ...

Americans are dying in young adulthood at alarming, and rising, rates, according to a new study published in JAMA Network ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

House Democrats press the Trump administration for clarity on how the president's order rescinding Biden's drug cost ...

Kailen Guffey is accused of second-degree murder for allegedly shooting Fattoum, 57, after he refused to turn over a black ...